Samrat Pharmachem Limited is engaged in the production of pharmaceutical chemicals like Iodine salts and Bromine salts. The Company's finished products are used in various industries, including pharmaceuticals, chemicals, food, fertilizer and salt.
Financials:
TTM EPS: 53.83
TTM PE: 7.25
P/B; 1.91
Face Value: 10
Mkt Cap (Rs. Cr.): 120
Dividend Yield: 0.26
Sector PE: 43.66
Book Value Per Share: 204.37
Positives:
Negatives:
Opinion: It has TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE. Can it reverse from this support zone ?
NOT A RECOMMENDATION. JUST FOR EDUCATION. Thanks.
Financials:
TTM EPS: 53.83
TTM PE: 7.25
P/B; 1.91
Face Value: 10
Mkt Cap (Rs. Cr.): 120
Dividend Yield: 0.26
Sector PE: 43.66
Book Value Per Share: 204.37
Positives:
- Company with Low Debt
- Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
- Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
- Book Value per share Improving for last 2 years
- Company with Zero Promoter Pledge
Negatives:
- Decline in Net Profit with falling Profit Margin (QoQ)
- Decline in Quarterly Net Profit with falling Profit Margin (YoY)
- Declining profits every quarter for the past 3 quarters
- Recent Results: Declining Operating Profit Margin and Net Profits (YoY)
- Weak Momentum: Price below Short, Medium and Long Term Averages
Opinion: It has TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE. Can it reverse from this support zone ?
NOT A RECOMMENDATION. JUST FOR EDUCATION. Thanks.
交易开始
CMP 405.交易开始
CMP 430
免责声明
这些信息和出版物并非旨在提供，也不构成TradingView提供或认可的任何形式的财务、投资、交易或其他类型的建议或推荐。请阅读使用条款了解更多信息。
免责声明
这些信息和出版物并非旨在提供，也不构成TradingView提供或认可的任何形式的财务、投资、交易或其他类型的建议或推荐。请阅读使用条款了解更多信息。